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BMI was 32,00 ± 0,38 kg\m2, level o f  leptin - 69,99 ± 5,3ng\ml, level o f  cholesterol - 5,86 ± 
0,77mmol\l and level o f  triglycerides - 2,67 ± 0,42mmol\l. Results o f  study suggest that level o f  leptin, 
cholesterol and triglycerides increased in patients with obesity and component o f metabolic syndrome.
Conclusions:
1. In patients with obesity and component o f  metabolic syndrome the level o f  leptin, 
cholesterol and triglycerides was increased.
2. Preventive health care and treatment o f  obesity promotes the prevention o f  increased levels 
of leptin, cholesterol and triglycerides.
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Introduction: Hypertrophic cardiomyopathy (HCM) accounts for 42% o f  childhood car­
diomyopathy and has an incidence o f  0.47/100,000 children (Colan SD, 2010). Clinical presentation 
is polymorphic, including sudden death may be the first symptom o f  HCM at any age. The risk o f  
sudden cardiac death (SCD) is >1% annually in unselected HCM patients but increases to 5% or 
more if risk factors are presents. According to a recent report on survival o f patients with HCM, a 
family history o f  cardiac sudden death was a risk factor for SCD in adult series, but it was much 
higher in patients <18 years o f  age (Dimitrow P., 2010). Several risk factors associated with an 
elevated risk o f  SCD in HCM adult patients have been identified, but risk factors in the pediatric 
population are not yet finalized.
Purpose and Objectives: The detection o f  unfavorable risk factors in the primary diagnosis 
of hypertrophic cardiomyopathy in children.
Materials and Methods: A retrospective study was performed on 7 children diagnosed primary 
with HCM, interned in departement o f  Pediatric cardiology o f  Child and Mother Institute (2009-2010). 
All subjects underwent detailed assessment that included clinical history (symptoms, when they started, 
date o f diagnosis o f  the disease, family history data on evolution, past and present therapy, etc.), clinical 
examination, 12-lead electrocardiogram (ECG), ECG Holter monitoring and echocardiographic study 
(EcoCG, M-mode, two dimensional and Doppler). Each clinical case was analyzed with reference to 
detection the presence o f unfavorable risk factors at primary diagnosis.
Results: The primary diagnosis o f  HCM was established at the age o f  the infant in 42,8% o f 
cases, o f  whom 2 patients had a positive family history. Most children (71,4% o f  cases) were 
suspected to specific symptoms: chest pain, dyspnea and intolerance at effort. Standard ECG 
determined left ventricular hypertrophy (LVH) in 100% o f  cases. The EcoCG measurements, 
allowed the establishment HCM phenotype: 4 (57%) patients having the symmetric form; 3 patients 
- asymmetric form (with the involvement o f  the interventricular septum (IVS), 3 patients had the 
thickness report IVS / LV posterior wall thickness > 1.3. Concomitantly standard EcoCG in rest 
allowed confirmation o f  the LV outlet tract obstruction (LVOT) to 3 patients, and 1 patient was 
appreciated the LVOT phenomenon by performing the effort EcoCG. In 5 patients (71,4%) was 
determined the significant increase LV mass myocardium, in 3 children were detected the increase 
of the left atrial cavity and 1 child - right ventricular involvement.
Conclusion: Primary diagnosis o f  HCM was suspected by cardiac symptoms; only 30% o f  
children were found preclinical and positive family history. Early emergence o f  symptoms, 
aggravated family history and listed EcoCG criteria: significant increase in LV mass, the LV outlet 
tract obstruction and right heart involvement, may be considered unfavorable risk factors in the 
evaluation o f  children with HCM, including for the SCD syndrome.
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